US BANCORP \DE\ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 69 filers reported holding AKERO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$114,816
-32.8%
2,270
-38.0%
0.00%
Q2 2023$170,932
+38.5%
3,661
+13.5%
0.00%
Q1 2023$123,388
-69.7%
3,225
-56.6%
0.00%
-100.0%
Q4 2022$407,328
+115.5%
7,433
+34.1%
0.00%
Q3 2022$189,000
+800.0%
5,541
+145.7%
0.00%
Q2 2022$21,000
+5.0%
2,255
+63.9%
0.00%
Q1 2022$20,000
-13.0%
1,376
+25.1%
0.00%
Q4 2021$23,000
-8.0%
1,1000.0%0.00%
Q3 2021$25,000
-66.7%
1,100
-63.7%
0.00%
Q2 2021$75,000
-35.3%
3,031
-24.2%
0.00%
Q1 2021$116,000
+510.5%
4,000
+433.3%
0.00%
Q2 2020$19,000
+18.8%
7500.0%0.00%
Q1 2020$16,0007500.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$168,435,00013.00%
venBio Partners LLC 2,444,311$63,063,0005.57%
Versant Venture Management, LLC 777,727$20,065,0002.08%
Vivo Capital, LLC 633,426$16,342,0000.73%
Redmile Group, LLC 2,322,557$59,922,0000.73%
Boxer Capital, LLC 831,495$21,453,0000.69%
Integral Health Asset Management, LLC 85,000$2,193,0000.65%
SILVERARC CAPITAL MANAGEMENT, LLC 35,179$908,0000.53%
HighVista Strategies LLC 27,739$716,0000.46%
Cormorant Asset Management, LP 742,549$19,158,0000.46%
View complete list of AKERO THERAPEUTICS INC shareholders